Finland· FI-REL-REL9779
Pimafucin
A natamycin product containing natamycin, registered in Finland by Paranova Oy.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Natamycin
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- A01AB10
- ATC class
- Natamycin
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natamycin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPIMAFUCINCHEPLAPHARM Arzneimittel GmbH, Greifswald
- United KingdomNatacyn 5% ophthalmic suspensionImported (United States)
- Japanピマリシン千寿製薬
- United StatesNATACYNHarrow Eye, LLC
- PolandPimafucinCHEPLAPHARM Arzneimittel GmbH
- NorwayNatacyn
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Pimafucin
- Hungary · Pimafucin
- Poland · Pimafucin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89b299a4-8b53-4cd9-ac4f-59e861d872e4 GET /v1/drugs/89b299a4-8b53-4cd9-ac4f-59e861d872e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "20",
"form": "tipat, suspensio",
"route": null,
"ddd_unit": "mg",
"strength": "25 mg/ml",
"atc_label": "natamysiini",
"ma_number": "13083",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL9779",
"authorised_at": "1999-05-03"
}See everything about natamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.